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Introduction
Breast cancer remains the second leading cause of death in women (1) . Persisting high mortality rate warrants deeper understanding of this complex disease. Breast tumors are composed of heterogeneous cell populations, some of which have stem cell-like properties that enable them to resist most therapeutic treatments (2) . It is known that adipose rich microenvironment of mammary glands, which is composed of mature adipocytes and adipose-derived stem cells (ADSCs), dynamically influence breast tumor development (3, 4) . Cancer cells are also reported to induce lipolysis of adipocytes where free fatty acids have been known to accumulate in cancer cells and promote its growth (5) . In addition, adipocytes in the vicinity of breast tumor cells exhibit altered biological characteristics such as over-expression of inflammatory cytokines, proteases, and collagens that are involved in remodeling of extracellular matrix (6) . Some of these properties are acquired due to breast tumor cells secreting pro-inflammatory interleukin-6 (IL-6) and Wnt3a that reactivates Wnt/β-catenin pathways in adipocytes to form adipocytederived fibroblasts (ADF) (7) . In return, these ADF and cancer-associated adipocytes (CAA) increase aggressive tumor behavior like invasiveness and angiogenesis (7, 8) .
Mammary adipose tissue also provides a reservoir of mesenchymal stem/progenitor cells or ADSCs that are recruited to the tumor mass in response to inflammation and hypoxic conditions (9) . These resident ADSCs, as well as recruited bone-marrow derived mesenchymal stem cells (BM-MSCs), constitute the mammary cancer stem cell (MCSC) populations that play a key role in promoting the initiation/progression of breast cancer (10) . Interestingly, breast-derived adipose stromal cells express significantly increased levels of genes implicated in cell growth, matrix deposition, remodeling and angiogenesis when compared to BM-MSCs, which have previously been implicated in breast tumor development (9) . In particular, ADSCs induce epithelial to mesenchymal transition (EMT) in a PDGFdependent manner (11) .
Although several lines of evidence have implicated white adipocytes in promoting aggressive breast tumor behavior, a few recent studies have also associated brown adipocytes with this complex disease 4 (12, 13) . Brown adipose tissue (BAT) has also been detected in postnatal mammary gland along with white adipocytes (14) . In spite of significant involvement of adipose tissue in progression of breast tumors, specific adipocyte characteristics that promote breast tumor development remain poorly understood. Identification and characterization of key players involved in early stages of tumor development could lead to effective therapeutic intervention to control breast cancer. This report provides significant evidence that expression of beige and brown adipose markers from host and tumor cells could influence breast tumor growth in nude mice. Therefore, therapeutic targeting of BAT has the potential of yielding beneficial effects for the treatment of breast cancer.
Materials and Methods

Human Cell Lines
The HMLE HRASV12 Tumors were excised at various time points and tumor weight was measured. In some cases, tumor volume was calculated as described previously (17, 18) . This study was carried out in strict accordance 
Histology
Immediately after excision from mice, tumors were placed in 2.5% glutaraldehyde in Millonig buffer. After 24 hours fixation tumors were washed three times with Millonig buffer for two hours and post-fixed in 1% osmium tetroxide for one hour. Osmium tetroxide crosslinks lipids and prevents loss of cytoplasmic lipid during subsequent tissue dehydration. Osmium tetroxide also stains lipid droplets brown (19) . Following three additional two-hour washes with buffer, the tumors were dehydrated with 70%, 90%, 95%, and 100% ethanol, and embedded in glycol methacrylate (Kulzer Technovit 7100, Electron Microscopy Sciences, Hatfield, PA) according to the manufacturer's protocol. From the methacrylate blocks, fivemicrometer thick sections were cut using a RM2255 microtome (Leica Microsystems, Buffalo Grove, IL), placed on glass slides, dried on a hotplate, and stained with 0.5% toluidine blue. Images were obtained using a standard Olympus BX51 bright field microscope with a DP-71 digital camera and DP Controller software (Olympus America, Cypress, CA).
Quantitation of lipids in cross-section of xenografts
To quantify the amount of lipids (including triglycerides) present in tumor cross section, the blob algorithm was used (20) . Using MATLAB, the images of the osmium tetroxide and toluidine-stained tissue sections were converted from RGBA to grayscale and processed; histogram equalization was used to enhance 6 the contrast in the images for better differentiation between tumor structures and low pass filtering was utilized to reduce pixilation. Then, blob analysis was performed, a process in which pixels whose intensity values (0 as black and 256 as white in image class uint8 or 8-bit image) fall within a specified range are retained as 1's in a binary image and those outside of the range are converted to 0's, and connected pixels whose values are 1's are grouped and labeled. Osmium tetroxide fixation makes lipid regions distinguishable from other tumor tissues because the osmium tetroxide stains lipid droplets brown, so pixels that depict these regions are of generally lower intensities than those of other tissues. The areas of the labeled groups are then calculated and the original image and blob-analyzed image are compared to determine which areas are truly areas containing high amounts of lipids. For each tumor section image, two pixel intensity ranges are used separately to obtain the total tumor section area and the total area of regions containing high amounts of lipids.
Immunolabeling
Immediately after excision from mice, some of the tumors were fixed in 5% formalin overnight after which they were dehydrated in ethanol and embedded in paraffin. Tumor sections (5-6μm) were deparafinized, and immunolabeling was performed as described previously (21) . Cells from dissociated HMLE HRASV12 xenografts (both transplantable and non-transplantable) were plated in six well plates and allowed to propagate for 48 hrs. Cells were fixed with 4% paraformaldehyde in 1x PBS for 30 min, washed , and incubated with blocking buffer (TBS pH 7.8, 5% normal goat serum, 1% BSA and 1% triton X-100) for 1hr. The following antibodies were used in our experiments: UCP1 (ab10983, Abcam), UCP2 (AB3226, Millipore, Billerica, MA); and UCP3 (ab3477, Abcam).
Quantitative Real-Time PCR
Total RNA isolated from flash-frozen xenografts or cells were subjected to reverse transcription, and the resulting cDNA was analyzed for various gene expression by real-time quantitative PCR using a 7500
Fast Real-time PCR System (Applied Bio Systems, Foster City, CA) and associated software as 
Double Immunofluorescence
Dissociated cells obtained from the xenografts were analyzed for co-localization of extracellular matrix proteins and adiponectin (Adipoq) with UCP1 using previously described methods (21) . Briefly, dissociated cells were seeded overnight on eight well chamber slides, fixed with 2% paraformaldehyde, blocked with normal goat serum containing 0.25% Triton X100. Cells were initially incubated with anti-UCP1 antibody followed by FITC (for co-localization with extra-cellular matrix proteins) or Texas-Red (for co-localization with adiponectin) conjugated secondary antibodies. Subsequently, the cells were further incubated with anti-ColA1, -Col3, -α-SMA, and FN or adiponectin followed by appropriate Texas-Red or FITC conjugated secondary antibodies for 1hr. Slides were further counterstained with DAPI and mounted in prolong anti-fade solution (Molecular Probes, Eugene, OR) (21) .
Cellular Oxygen Consumption
Oxygen consumption rates (OCR) of single cell suspensions obtained from 7-and 12-week xenografts were measured in an XF24 Extracellular Flux Analyzer (Seahorse Bioscience, North Billerica, MA, USA).
Cells (4x10
4 /well) were plated in DMEM containing 10% FBS and incubated overnight at 37°C with 5% CO 2 . The day of the assay, medium was replaced by un-buffered DMEM supplemented with 25 mM glucose, and cells were incubated at 37°C in a CO 2 -free incubator for 2 hr before oxygen consumption rate (OCR) was recorded. During the assay, 0.5 μM carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) was injected to deduce the maximal respiration capacity (23, 24) . 
Human Tumors
Statistical Analysis
Data are presented as mean ± SD, and differences between groups were analyzed using ANOVA. If the overall ANOVA revealed significant differences, then pair-wise comparisons between groups were performed by Newman-Keuls multiple group test. All comparisons were two-tailed and p<.05 were considered statistically significant. The experiments were repeated at least three times, and data from representative experiments are shown. preserve the lipid content within the xenografts (5-7 weeks), tissues were fixed with glutaraldehyde and post-fixed with osmium tetroxide that stains and cross-links lipid droplets. A systematic analysis revealed that only T tumors contained cells with multi-locular lipid droplets, a morphology that is characteristic of beige/brown adipocytes ( Fig. 1D-E, Supplementary Fig. S1.B) . A quantitative analysis of lipids including triglycerides was performed in cross section of osmium tetroxide infiltrated xenografts (5 week) using blob algorithm with MATLAB software as explained in the Method Section. We have analyzed 3 xenografts (4 sections from each xenograft) and found variations (2-6%) in the total area occupied by lipids in the cross-section of respective xenografts. Quantitation from one of the xenografts analyzed is shown ( Supplementary Fig. S1C ). Cells cultured from dissociated T xenografts stained positive for uncoupling protein 1 (UCP1), which is predominantly expressed only in beige and brown adipocytes (25) ( Supplementary Fig. S1D ). In addition, cells from these xenografts also stained for UCP2, and UCP3, whereas cells from NT tumors were negative for these uncoupling proteins ( Supplementary Fig. S1D ).
Results
Increased
We further immunolabeled paraffin embedded sections of xenografts from HMLE HRASV12 for UCP1 and these immunolabeling experiments showed that lipid-filled cells expressed UCP1 protein (Fig. 1F) . In addition to the uncoupling proteins, we analyzed the expression levels of Prdm16, a master regulator of brown fat lineage and Pgc1, a transcriptional coactivator of Prdm16 expressed in brown adipocytes (26, 27) . We also examined in the xenografts, the expression of Cebpa, and Pparg, which are key transcription factors promoting adipogenesis (24) . Quantitative PCR analysis of T tumors (5 weeks) using human specific primers showed significantly increased expression of key brown adipose specific markers including Ucp1 (12.5±2.7 fold), Ucp3 (7.4±1.8 fold); Prdm16, (4.7±1.2 fold), Pgc1 (3.4±0.9 fold), Cebpa (5.8±1.4 fold), and Pparg (2.7±0.8 fold) (Fig 1G) (25, 26) . It has been reported Ucp1 and Prdm16 are expressed in both inducible beige (which originates from non-Myf5 WAT), as well as in classical brown adipocytes (which originate from Myf5-expressing progenitor populations) (28) . Gene expression levels for additional markers characteristic of both beige adipocytes such as Cd137 (3.7±0.5 fold); and Tbx1 ( Fig. 1H ). Zeb2, which is associated with aggressive tumor behavior (29) including epithelial to mesenchymal transition (EMT) was significantly increased (4.6±0.7 fold) only in T xenografts (Fig. 1G ).
Increased protein levels of UCP1, UCP3, PRDM16, Myf5, adipocyte-specific transcription factors PGC-1α and PPARγ were also found in T tumors when compared to NT (Fig. 1I ). These data shows the expression of beige and brown adipose markers in transplantable xenografts from HMLE HRASV12 .
Both tumor cells and host contribute to the increase in beige/brown adipose markers HMLE
HRASV12 xenografts
Since host microenvironment is known to significantly contribute to tumor progression (30), we further set out to distinguish the contribution of the host as well as the implanted tumor cells themselves for the expression of beige/brown adipose markers in xenografts. For this purpose, primers designed from human (h) and mouse (m) Ucp1 and Prdm16 (beige/brown adipocytes), Cd137 and Tbx1 (beige adipocytes) as well as Myf5, Eva1 and Oplah1 (classical brown adipocytes) genes were tested for species specificity. Species specificity of each of the primer pairs was pre-determined by its ability to amplify respective genes from known specific tissues that overexpress them ( Supplementary Fig. S2 ).
Mouse brown adipose tissue (BAT) that is known to have increased expression of Ucp1, and Prdm16 was used as a positive control for mouse primers ( Supplementary Fig. S2 ). Human peri-adrenal adipose tissues from pheochromocytoma patients, which are known to be enriched in beige/brown adipocytes (31), were used as a positive control to determine the specificity of human primers. Only those mouse or human primer sequences ( Fig. S3 ). Similar changes were found when these cells were implanted at other subcutaneous sites ( Supplementary Fig. S3 ). We also injected tumor cells in the inguinal mammary glands of the host and found similar increase in beige/brown adipose markers in the xenografts (data not shown). These experiments suggest that increased expression of beige and brown adipose markers in the HMLE HRASV12 xenografts was independent of the site of implantation of the tumor cells. We further examined morphological characteristics as well as the expression of various proteins associated with beige/brown adipose during the course (1-15 week) of xenograft development.
Temporal regulation of UCP1 expression during xenograft development
Morphological characteristics were examined in formalin-fixed HMLE HRASV12 xenografts that were infiltrated with osmium and embedded in paraffin. Representative pictures (low and high magnification) of eosin/hematoxylin stained xenograft (5 week) is shown ( Fig.2 A-B) . We further performed western blot analysis of pooled tumor samples at intervals from 1-15 weeks, which revealed a dynamic pattern of UCP1 expression during tumorigenesis (Fig. 2C-D) . The levels of UCP1 and UCP3 proteins were temporally regulated during tumorigenesis, with peak levels at weeks 5-7 for UCP1 and UCP3 (Fig. 2D ).
PRDM16 levels were increased as early as 1 week after implantation of the cells while Myf5 peaked between 3-5 weeks of tumorigenesis. On the other hand, increased levels of CD137 were detected as early as 1 week of implantation of HMLE HRASV12 cells. Also, COX IV, a mitochondrial protein, as well as PGC-1α, PPARγ and C/EBP-α followed dynamics similar to UCP1, peaking at the middle stages of tumor growth (Fig. 2D ). UCP2 expression was detected only in late stage tumors (Fig. 2D) . Quantification by fluorescence activated cell sorting (FACS) confirmed increased PRDM16 (7.8% and 3.6%) expression in weeks 1 and 3 respectively in addition to increase in UCP1 (0.2% and 6.8%) and UCP3 (0.1% and 1.6%) from week 1 to 5 respectively (Fig. 2E) . Since xenografts that contained beige/brown adipose exhibited a growth advantage over NT xenografts, we examined expression of aggressive tumor markers in these tumors. The levels of vascular endothelial growth factor (VEGF), proliferation marker, cyclin D1 as well as extracellular matrix proteins, collagen A1 (ColA1), smooth muscle actin (SMA) and fibronectin (FN) were assessed by Western blot, We found increased levels of VEGF, cyclin D1, ColA1, SMA and FN in T tumors when compared to NT (Fig. 2F) . We further examined the presence of extracellular matrix proteins with UCP1 expression in sections of T xenografts by double immunofluorescence. We found extracellular matrix proteins in close proximity to UCP1-expressing cells in the xenografts (Supplementary Fig. S4A ). We further examined whether UCP1-expressing cells also expressed adiponectin, which is highly expressed in adipocytes. Cells from dissociated xenografts were fixed and stained for UCP1 (Texas Red) and adiponectin (FITC). We found UCP1-expressing cells also co- Supplementary Fig. S4B ). Since brown adipocytes are significantly enriched in mitochondria, we analyzed the cellular bioenergetics of cells from (Fig. 2G) .
The increase in cellular bioenergetics was in agreement with the enhancement of mitochondrial protein expression observed at 5-7 weeks (i.e. UCP1 and COX IV in Fig. 2D ). Our data, therefore, shows temporal regulation of beige and brown adipose specific proteins during HMLE HRASV12 xenograft development.
Depletion of UCP1 and Myf5 positive population reduced xenograft development
Since increased brown and beige adipocyte characteristics were found only in transplantable xenografts, (Fig. 3A) . A second assay was based on the observed decline in UCP1 levels in late-stage xenografts (Fig. 2D) . We assessed the potency of cells (2x10 6 ) from 7-week (high UCP1 levels) and 15-week (low UCP1 levels) xenografts to form tumors in mice, and observed that cells from 15-week xenografts produced delayed growth of (Fig. 3B) .
We next investigated whether PRDM16 expressing progenitor populations have a relationship to mammary cancer stem cells (MCSC), which have a key role in mammary tumor initiation and progression (32) . The levels of aldehyde dehydrogenase 1 (ALDH1), a marker of MCSC, were highest in very early stage xenografts (7.4% of cells at 1 week) and subsequently declined (to 2.8% at 3 weeks) (Fig. 3C) . We also detected the highest levels of PRDM16 in very early stage xenografts (Fig. 2D) , raising the possibility that a sub-population of MCSCs may also be expressing PRDM16. Consistent with this hypothesis, FACS analysis identified that 4.2% and 1.9% cells were positive for both ALDH1 and PRDM16 from 1-week and 3 week xenografts (Fig. 3C) . We further examined Myf5 expressing cells in paraffin-embedded sections of xenografts by immunohistochemistry. A representative picture of Myf5 expression in undifferentiated cells in xenograft (3 week) is shown (Fig. 3D) . For quantitation of Myf5 expressing cells in the xenografts, cells from dissociated xenografts were incubated with Myf5 antibody /FITC conjugated secondary antibody and subjected to FACS. While the % of Myf5 in the xenografts varied (0.2%-5.6%), a representative picture of cell sorting for Myf5 (2.7%) is shown (Fig. 3E) . We further compared the potency of Myf5 depleted populations when compared to control cells in establishing xenografts. Analysis at 4 week showed that when compared to control cells (2x10 6 ), there was a lag in the Myf5-depleted (2x10 6 ) population to form xenografts (Fig. 3F) . The above data suggests that UCP1 expressing beige/brown adipose along with Myf5 expressing cells contribute towards HMLE HRASV12 xenograft development.
Pre-treatment of HMLE HRASV12 cells with brown adipocyte differentiation medium (BADM) increased beige adipocytes and xenograft growth
Since beige adipocytes, which could be induced, were present in the xenografts, we further examined the expression of inflammatory markers COX-2 and p38 MAP Kinase, both of which have been demonstrated to play key roles in promoting induction of beige adipocytes (33) . COX-2 was expressed at highest levels at early stages of xenograft development (Fig. 4A) , while the expression of phosphorylated p38 MAP Kinase followed dynamics (Fig. 4A ) similar to that observed for UCP1 (Fig. 2D) . Since cells from UCP1-enriched xenografts had growth advantage (Fig. 3B) , we further examined whether deliberate inducement of beige adipocyte characteristics increased tumorigenic capacity. To test this, we stimulated primary cultures obtained from T xenografts with modified BADM containing 20nM insulin, 0.5 mM 3-isobutyl-1-methylxanthine (IBMX), 0.5µM dexamethasone, 0.125 nM indomethacin, and 1nM T3 (27) for 48 hrs and implanted induced and un-induced cells (2x 10 6 ) subcutaneously (posterior ventrolateral site).
Analysis of the xenografts (2 week) showed that beige adipocyte-specific markers contributed from both tumor cells and the host was significantly increased in the induced when compared to un-induced xenografts (Fig. 4B) . We found increased expression of hUCP1 (1.8±0.4), hPRDM16 (2.4±0.2), hCD137 (2.7 ±0.02) and hTBX1 (1.8 ±0.38) as well as mUCP1 (4.7±0.7), mPrdm16 (2.8±0.2), mCd137 (6.5 ±0.4) and mTbx1 (7.2 ±0.1.8) in the induced when compared to un-induced xenografts (Fig. 4B) . When the volumes of xenografts were examined, those from BADM-treatment generated larger tumors Fig. 5E and 5J) . A time course experiment with the xenografts that were allowed to grow for 3, 5 or 15 weeks was performed to examine the dynamics of beige and brown adipocyte-specific proteins during xenograft development. We found UCP1, PRDM16, Myf5 and CD137 protein levels exhibited a similar temporal regulation (Fig. 5F, 5K ) as observed in the original HMLE HRASV12 xenografts (Fig. 2D) . These experiments show an increased expression of genes characteristic of beige and brown adipose in xenografts from breast cancer cell lines. Table 2 ). All 3 PDX (PDX1, PDX2 PDX3) after 3-7months of growth (~0.5 cm in diameter) were excised, fixed with glutaraldehyde, and post-fixed with osmium. Systematic analysis of these xenografts revealed presence of typical multi-locular lipid-droplet-filled cells, characteristics of beige/brown adipocytes (Fig. 6A) . We further analyzed PDX2 for contributions from tumor cells and host in increasing the beige/brown adipocytes. We found that when compared to the original tumor pieces before implantation, there was increase in hUCP1 (4.3±1.2 fold), hCD137 (3.7±1.2 fold), hTBX1 (4.5±0.6 fold) and hMYF5 (1.6±0.1 fold).
In addition, compared to the control host tissue at the site of implantation, there was increase in mUcp1 (7.4±2.3 fold), mCd137 (10.2±3.2 fold), mTbx1 (12.0±1.2 fold) and mMyf5 (2.1±0.1 fold) (Fig. 6B) .
Furthermore, western blot analysis showed increased expression of UCP1 in all the PDX, while CD137 was detectable only in PDX1 and PDX2 (Fig. 6C) .
Moreover, immunoblot analysis of 59 human breast tumor samples showed that the majority (74.5%) had detectable UCP1 protein levels (Supplementary Table 3 ) (Fig. 6D) . Representative pictures of different subtypes of human breast tumors immunolabelled with UCP1 antibody are shown (Fig. 6E ). Collectively our data suggests expression of beige/brown adipose markers in xenografts could influence breast tumor development and could provide a rationale target for therapeutic interventions (Fig. 6F) .
Discussion
Mammary gland is a dynamic heterogeneous adipose rich organ that could serve as a fertile ground for the development of breast cancer (34) during pregnancy and lactation (35) . BAT secrete a variety of adipokines, express high levels of glucose transporter-4 (GLUT4), and consume significantly higher levels of glucose (36) . Using (12) . In addition, persistent deposition of brown adipocytes has been detected in the mammary glands of BRCA1 mutant mice (13) . Increased BAT in the mammary glands of these mutant mice has been correlated with up-regulation of the angiogenic marker CD31 (13) . Also, a recent study shows a higher browning of mammary fat close to malignant breast tumors when compared to those in the vicinity of benign lesions (37) . There is also report that white-to-brown transdifferentiation of omental adipocytes has been found in patients affected by pheochromocytoma (38) .
In order to identify key adipocyte characteristics that may promote breast tumor development, we systematically analyzed xenografts obtained from various stages of tumor growth. Our study shows, for the first time to our knowledge, increase of beige and brown adipose markers in xenografts from three established breast cancer cell lines and in patient-derived xenografts. In this study, we present that multiple line of evidences obtained from our experimental findings demonstrate the increased expression of key markers for beige/brown adipose during breast tumor development. We further show the involvement of both the host as well as tumor cells in the increased expression of beige and brown adipose in the xenografts. Notably, this increase of beige and brown adipose markers from the tumor cells as well as the host was independent of the site of implantation of the tumor cells. Although expression of UCP1 has been mainly reported in beige/brown adipose tissues, its expression has also been detected in macrophages (39) , pancreas (40) and nervous tissues of torpid animals (41).
Fate of mammary epithelium, which sits in a complex niche, depends on signals from extracellular matrix as well as systemic hormonal milieu (42) . Extracellular matrix, a highly variable component of the mammary gland, is composed of proteins such as collagens, laminins, and adiponectin as well adifferentiated and undifferentiated cells of hematopoietic origins, adipocytes and fibroblasts (43) . Extracellular matrix of breast tumors is also complex and key determinant of cancer progression (44) . 
Significant amount of developmentally regulated brown adipose tissue has been found in the stromal compartment of the mammary gland (45) . Using BAT-depleted mouse model, it has been reported that depletion of mammary BAT in early postnatal development induces epithelial differentiation (14) . Data from our study suggests that depletion of UCP1 and Myf5 positive cells significantly reduces tumor growth. The precise mechanisms by which beige/brown adipocytes contribute to xenograft growth are unknown and are a subject of future investigation. There is a possibility that increase in UCP1 expressing beige/brown adipocytes promotes expansion of subsets of mammary cancer stem cells, which facilitates xenograft growth. There is a possibility that disruption of proton-motive forces by increased UCP1 expression may lead to acidic microenvironment, which has been implicated in promoting tumor growth (46, 47) . In addition, accumulation of lipids in brown adipocyte-like cells may promote fatty acid metabolism and metabolic reprogramming that could influence tumor growth. It will be interesting to explore whether up regulation of beige/brown adipocytes facilitates the formation of extracellular matrix that may contribute to expansion of subsets of cancer stem cells.
MCSCs constitute a heterogeneous pool of progenitor populations that influence different stages of breast tumor development (48) . Aggressive breast tumors have high MCSC content that promotes not only progression of the disease but also its recurrence and metastasis (49) . As few as 500 stem cell/cancer stem cells, that express aldehyde dehydrogenase-1 (ALDH1) in aggressive human breast tumors, have been found to initiate xenograft formation in nude mice (50) . However, different subsets of MCSCs have not been identified and characterized due to lack of specific markers. We report for the first time that in addition to an increase in ALDH1 expression, there was an expansion of a sub-set of MCSCs that expressed PRDM16 during xenograft growth from established human breast cancer cells.
PRDM16 has been established as a master regulator of the brown adipocyte differentiation program (26, 51) . In presence of PRDM16, Myf5 + precursor populations acquire brown fat characteristics specific for "classical" brown adipocytes (52) . On the other hand, PRDM16 can also influence the fate of Myf5 ─ precursors present mostly in the white adipocytes to acquire brown-like phenotype expressing "beigespecific" markers (53) . We observed significant enrichment of both classical BAT progenitors including 
Myf5 and Oplah, as well as the beige adipocyte-specific markers Cd137 and Tbx1 during xenograft development, suggesting that both populations increase UCP1 expression as well as contribute to breast tumor development.
It has been well demonstrated that breast tumor cells recruit BM-MSCs, hematopoietic cells including macrophages, as well as many other cell types from the host to promote its growth (53) (54) .
Since substantial amount of beige adipose markers of host origin was found in the xenografts, we have been examining whether they were recruited from the microenvironment or from distant sites of the host.
After extensive analysis of many adipose depots from the host, both at the site of implantation of the tumor cells as well as from distant sites, we found higher beige adipocytes of host origin within the tumor mass. There is a possibility that beige adipocytes in the xenografts might have been recruited from a yet unidentified source in the host. Since beige adipocytes are inducible, we are also considering a possibility that their increase within the tumor mass could be due to recruitment of WAT in the xenografts where they get transdifferentiated to beige adipocytes. Another possibility under consideration is that the xenografts recruit progenitors of beige adipocytes, which are usually Myf5 ─ precursors, known to reside in the vicinity of WAT and induce their differentiation. A large number of inducers of beige adipocytes including cytokines, adipokines, M2 macrophages, BMP4 and BMP7 have been reported (55) . Examining specific inducers that contribute to the increase of beige adipocytes could enhance our understanding of the disease for effective therapeutic interventions. In addition to the host, the tumor cells themselves contributed to the increase in beige adipose markers found in the xenografts. The fold increase of the beige adipose markers from the tumor cells appeared modest because of high basal levels from which the fold changes in the xenograft were calculated.
Our study also provides evidence that beige adipocytes could play a role in breast tumor development. Cyclooxygenase-2 (COX-2) is a rate-limiting enzyme in prostaglandin synthesis, and promotes breast cancer progression spanning pre-malignant phenotype to clinical metastasis (56).
Epidemiological evidence suggests that incidence of many cancers including those in the breast is inversely related to the use of aspirin and nonsteroidal anti-inflammatory drugs, which non-specifically inhibit cyclooxygenases (57) . More recently COX-2, which is a downstream effector of β-adrenergic receptor (AR) signaling in WAT, has been found to stimulate the induction of BAT in WAT depots (33) . In our study, treatment of cells with modified BADM in vitro induced beige adipocyte characteristics, and larger xenografts in vivo. Also, inhibition of COX-2 but not COX-1 reduced the levels of UCP1 and PRDM16, as well as tumor size. We found brown adipocyte characteristics in our PDX model of human breast tumors, suggesting that they may contribute to human breast tumor development. Our work may explain why inhibition of β-AR/ COX-2 signaling has previously been shown to suppress tumor growth in preclinical models (58) . Understanding key signaling pathways in beige/brown adipocytes that contribute to breast tumor progression will enable us to develop a novel therapeutic strategy to control breast tumor 
